Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma.
about
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical ImmImmunoglobulin E-mediated airway inflammation is active in most patients with asthma.Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.Repeated β2-adrenergic receptor agonist therapy attenuates the response to rescue bronchodilation in a hyperoxic newborn mouse model.Special considerations for adolescent athletic and asthmatic patients.Assessment of pediatric asthma drug use in three European countries; a TEDDY study.Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.Three generations of ongoing controversies concerning the use of short acting beta-agonist therapy in asthma: a review.Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe AsthmaMeta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.Pharmacogenomics of long-acting β2-agonists.The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot studyRisk versus benefit considerations for the beta(2)-agonists.Attenuation of airway smooth muscle contractility via flavonol-mediated inhibition of phospholipase-Cβ.In vitro effects of Beta-2 agonists on skeletal muscle differentiation, hypertrophy, and atrophy.Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids.The lectin-like domain of tumor necrosis factor improves lung function after rat lung transplantation--potential role for a reduction in reactive oxygen species generation.Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment.Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.Differential desensitization of homozygous haplotypes of the beta2-adrenergic receptor in lymphocytesAn estimation of beta 2-adrenoceptor reserve on human bronchial smooth muscle for some sympathomimetic bronchodilators.The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxideBeta-2 adrenergic receptor genetic polymorphisms and asthma.An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.The adult asthmatic.β1, β2, and β3 adrenoceptors and Na+/H+ exchanger regulatory factor 1 expression in human bronchi and their modifications in cystic fibrosis.Potential masking of airway eosinophilic inflammation by combination therapy in asthma.The Sophora flavescens flavonoid compound trifolirhizin inhibits acetylcholine induced airway smooth muscle contraction.Beta-agonists: all the facts please.Faut-il éviter les β-agonistes dans les cas de bronchopneumopathies chroniques obstructives modérées et graves?: OUI.Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients
P2860
Q24816932-6C25BC38-6574-406B-A535-C0A92FB5A117Q28275393-017799D9-6C21-4B00-BABC-F5D0F630CE39Q30444397-0F1FFC2D-3575-4C31-928E-FB946BF2357CQ33928874-2AF15CA2-923F-4140-9BC0-FB0BEF5B74F0Q34051397-D8BAC222-00FD-4938-89DF-6775AF421A8EQ34394995-E9F90187-1369-41AB-A177-F7DD4D2BB3B0Q34467637-7D237965-5994-4E7F-996F-A4F4643B727DQ34604746-03EEB651-59DA-424A-98D4-8F3AB4A4A9D5Q34688018-38E73523-9C70-461B-9654-436D8258BAFFQ34747731-8C8E6E25-E768-4AAE-A906-B7B7D9BDC038Q35645970-D53429AB-EE8C-48E6-BB14-FB46B02F41D6Q35696088-5FE5C4CE-42AD-4F3F-8C7A-F0C59E5F526AQ35734012-B30FEE5F-AA9A-49CB-A9A6-3885D3ADA840Q36477727-4B13C16D-5B5D-45A6-B5E4-BFF60638369BQ36582709-C0C50907-5FA6-442D-8FCC-66AA738576E5Q36811236-FE75036C-58D0-41CA-ABA7-9F7A9C7D5DE9Q36834807-4AE6D581-9EDE-4060-ACC1-8DC0B1A0D0CEQ36924300-E2BA737C-B9CC-478E-B98B-9F6B66EDE555Q36995337-C0839A7C-6CFD-4301-81AC-D571C5984571Q37017238-CFF2DBDD-7BCA-4DA9-BB64-CADEA644264CQ37145976-FC0F3D9C-94DA-4255-A9BF-60BC50C58844Q37151236-365929B7-0CE7-464B-8696-673AF2FEBF67Q37282807-1F7E36FA-005C-4D3F-9FA6-B205CF0DC9E3Q37481283-D95F19CE-9DBE-460B-B54C-BCCEE3022AAAQ37481301-64DA5F8B-62B9-461C-B470-2CC8ED024C00Q37566530-866BD10F-71AF-4CB1-B87E-444585BF1E63Q37696542-90B0CD48-6A24-4351-A2CF-D7568638352AQ37735203-18E0287C-2859-4ECD-A0E2-8F93719E2097Q37855658-7293AB49-D242-4844-BCCD-7332364A1735Q39732208-0B7C8642-049C-4D75-AA92-4E8995B06061Q41970033-3A356C12-0E94-43C2-9E35-1C24A0573336Q42762507-FDF75CA3-A464-42D3-9C29-459AD0FD0CF3Q43011925-2AD6AD42-CB05-43ED-AE0A-4DBEE9608C62Q55180464-1AE12D22-25E0-4832-82F4-45C10945CDA1Q57638826-14FB45D4-65B7-4110-9241-41AC1C9A5720
P2860
Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Meta-analysis: respiratory tol ...... t use in patients with asthma.
@en
Meta-analysis: respiratory tol ...... t use in patients with asthma.
@nl
type
label
Meta-analysis: respiratory tol ...... t use in patients with asthma.
@en
Meta-analysis: respiratory tol ...... t use in patients with asthma.
@nl
prefLabel
Meta-analysis: respiratory tol ...... t use in patients with asthma.
@en
Meta-analysis: respiratory tol ...... t use in patients with asthma.
@nl
P2093
P1476
Meta-analysis: respiratory tol ...... t use in patients with asthma.
@en
P2093
Edwin E Salpeter
Shelley R Salpeter
Thomas M Ormiston
P304
P356
10.7326/0003-4819-140-10-200405180-00018
P407
P577
2004-05-01T00:00:00Z